Inspections, Compliance, Enforcement, and Criminal Investigations
Hsu's Ginseng Enterprises, Inc. - Close Out Letter 2/6/12
Department of Health and Human Services
|Public Health Service|
Food and Drug Administration
|Minneapolis District Office|
250 Marquette Avenue, Suite 600
Minneapolis, MN 55401
Telephone: (612) 758-7114
FAX: (612) 334-4142
February 6, 2012
Paul C. Hsu
Hsu's Ginseng Enterprises, Inc.
T6819 County Highway W, P.O. Box 509
Wausau, Wisconsin 54402
Dear Mr. Hsu:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter MIN 11-29 dated May 13, 2011. Based on our evaluation, it appears that you have addressed the violation contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Tyra S. Wisecup